Apoptotic tumor-cell death in response to cell proliferation is influenced by p53 status in resected non-small cell lung cancer

This publication has 26 references indexed in Scilit:

• p53 Status Predicts the Efficacy of Postoperative Oral Administration of Tegafur for Completely Resected Non-small Cell Lung Cancer^†
  Japanese Journal of Cancer Research, 1999
• Lewis Y antigen expression and postoperative survival in non–small cell lung cancer
  The Annals of Thoracic Surgery, 1998
• Evidence that Expression of a Mutated p53 Gene Attenuates Apoptotic Cell Death in Human Gastric Intestinal‐type Carcinomas in vivo
  Japanese Journal of Cancer Research, 1997
• Suppressed Apoptotic Induction in Esophageal Squamous Cell Carcinomas Expressing Extensive p53 Protein
  Japanese Journal of Clinical Oncology, 1996
• Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression
  Nature Medicine, 1995
• Mutations of the p53 Gene as a Predictor of Poor Prognosis in Patients With Non-Small-Cell Lung Cancer
  JNCI Journal of the National Cancer Institute, 1993
• Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
  The Journal of cell biology, 1992
• p53, guardian of the genome
  Nature, 1992
• The p53 tumour suppressor gene
  Nature, 1991
• Cyclin/PCNA is the auxiliary protein of DNA polymerase-δ
  Nature, 1987